• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种、进化与疫苗效力的变化:一个理论框架

Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework.

作者信息

McLean A R

机构信息

Laboratoire des dynamiques lymphocytaires, Institut Pasteur, Paris, France.

出版信息

Proc Biol Sci. 1995 Sep 22;261(1362):389-93. doi: 10.1098/rspb.1995.0164.

DOI:10.1098/rspb.1995.0164
PMID:8587880
Abstract

The evolution of vaccine-resistant strains of infectious agents is potentially a huge problem for their control by immunization. Yet, for many infectious diseases, it has been possible to drive them to the verge of extinction without vaccine escape mutants arising. This paper establishes a theoretical framework within which to ask why this should be so, what properties of vaccines allow this situation and what might happen in situations where vaccine escape mutants do arise.

摘要

传染病疫苗抗性菌株的进化对于通过免疫接种来控制这些疾病而言可能是一个巨大的问题。然而,对于许多传染病来说,已经有可能将它们逼至灭绝边缘,而不会出现疫苗逃逸突变体。本文建立了一个理论框架,用以探讨为何会出现这种情况、疫苗的哪些特性促成了这种局面,以及在出现疫苗逃逸突变体的情况下可能会发生什么。

相似文献

1
Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework.疫苗接种、进化与疫苗效力的变化:一个理论框架
Proc Biol Sci. 1995 Sep 22;261(1362):389-93. doi: 10.1098/rspb.1995.0164.
2
Imperfect vaccination: some epidemiological and evolutionary consequences.不完全疫苗接种:一些流行病学和进化方面的后果。
Proc Biol Sci. 2003 Jun 7;270(1520):1129-36. doi: 10.1098/rspb.2003.2370.
3
Vaccine administration in children with chronic kidney disease.慢性肾病患儿的疫苗接种
Vaccine. 2014 Nov 20;32(49):6601-6. doi: 10.1016/j.vaccine.2014.09.038.
4
Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneity.在疫苗相关异质性情况下,根据急性传染原的流行情况估算疫苗效力。
Math Biosci. 1993 Sep-Oct;117(1-2):271-81. doi: 10.1016/0025-5564(93)90028-9.
5
Multiple dose vaccination against childhood diseases: high coverage with the first dose remains crucial for eradication.针对儿童疾病的多剂次疫苗接种:首剂高接种率对于根除疾病仍然至关重要。
IMA J Math Appl Med Biol. 2000 Sep;17(3):201-12.
6
Adult immunization in India: Importance and recommendations.印度的成人免疫接种:重要性与建议。
Hum Vaccin Immunother. 2015;11(9):2180-2. doi: 10.4161/hv.29342. Epub 2014 Jun 18.
7
Measurement of vaccine-derived immunity: how do we use all the data?
Expert Rev Vaccines. 2012 Jul;11(7):747-9. doi: 10.1586/erv.12.47.
8
Promoting life course vaccination.促进全生命周期疫苗接种。
Rejuvenation Res. 2011 Feb;14(1):75-81. doi: 10.1089/rej.2010.1078. Epub 2011 Jan 5.
9
Why do we have vaccines for some infectious diseases but not for others?
Int J Med Microbiol. 2008 Jan;298(1-2):1-2. doi: 10.1016/j.ijmm.2007.08.003. Epub 2007 Sep 21.
10
Strategies for decision-making on vaccine use: the French experience.疫苗使用决策策略:法国的经验。
Expert Rev Vaccines. 2015 Jul;14(7):917-22. doi: 10.1586/14760584.2015.1035650. Epub 2015 Apr 25.

引用本文的文献

1
Non-pharmaceutical interventions and the emergence of pathogen variants.非药物干预措施与病原体变体的出现。
Evol Med Public Health. 2022 Dec 19;11(1):80-89. doi: 10.1093/emph/eoac043. eCollection 2023.
2
Robust models of disease heterogeneity and control, with application to the SARS-CoV-2 epidemic.疾病异质性与控制的稳健模型及其在SARS-CoV-2疫情中的应用。
PLOS Glob Public Health. 2022 May 9;2(5):e0000412. doi: 10.1371/journal.pgph.0000412. eCollection 2022.
3
Can breeders prevent pathogen adaptation when selecting for increased resistance to infectious diseases?
当选择增加对传染病的抵抗力时,饲养员能否防止病原体适应?
Genet Sel Evol. 2022 Nov 8;54(1):73. doi: 10.1186/s12711-022-00764-0.
4
Effects of epistasis and recombination between vaccine-escape and virulence alleles on the dynamics of pathogen adaptation.疫苗逃逸和毒力等位基因之间的上位性和重组对病原体适应性动态的影响。
Nat Ecol Evol. 2022 Jun;6(6):786-793. doi: 10.1038/s41559-022-01709-y. Epub 2022 Apr 18.
5
Understanding the devastating second wave of COVID-19 pandemic in India.了解印度第二波毁灭性的新冠疫情。
Am J Hum Biol. 2021 Nov;33(6):e23671. doi: 10.1002/ajhb.23671. Epub 2021 Sep 1.
6
Human Papillomavirus Genotype Replacement: Still Too Early to Tell?人乳头瘤病毒基因型替换:言之尚早?
J Infect Dis. 2021 Aug 2;224(3):481-491. doi: 10.1093/infdis/jiaa032.
7
Imperfect vaccine and hysteresis.不完美疫苗和滞后现象。
Proc Biol Sci. 2019 Jan 16;286(1894):20182406. doi: 10.1098/rspb.2018.2406.
8
Managing the emergence of pathogen resistance via spatially targeted antimicrobial use.通过空间靶向抗菌药物使用来管理病原体耐药性的出现。
Evol Appl. 2018 Sep 26;11(10):1822-1841. doi: 10.1111/eva.12683. eCollection 2018 Dec.
9
Estimating Vaccine-Driven Selection in Seasonal Influenza.估算季节性流感疫苗驱动的选择。
Viruses. 2018 Sep 18;10(9):509. doi: 10.3390/v10090509.
10
HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine.HIV 群体水平上的适应性可以迅速降低部分有效疫苗的效果。
Vaccine. 2018 Jan 25;36(4):514-520. doi: 10.1016/j.vaccine.2017.12.004. Epub 2017 Dec 11.